Evidence for the involvement of nitric oxide in A2B receptor-mediated vasorelaxation of mouse aorta

被引:55
作者
Ansari, Habib R.
Nadeem, Ahmed
Talukder, M. A. Hassan
Sakhalkar, Shilpa
Mustafa, S. Jamal [1 ]
机构
[1] W Virginia Univ, Dept Physiol & Pharmacol, CIRCS, Robert C Byrd Hlth Sci Ctr, Morgantown, WV 26506 USA
[2] Ohio State Univ, David Heart & Lung Res Inst, Columbus, OH 43210 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2007年 / 292卷 / 01期
关键词
adenosine; endothelium;
D O I
10.1152/ajpheart.00593.2006
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
We have investigated the role of adenosine and its analogs on vasorelaxation of mouse aorta in intact endothelium with rank order of potency as follows: 5'-N-ethylcarboxamidoadenosine (NECA) > 2-chloroadenosine > adenosine >> CGS-21680, which is consistent with the profile of A(2B)-adenosine receptor (A(2B)AR). In endothelium-intact tissues, acetylcholine produced relaxation ranging from 65 to 80% in phenylephrine (PE, 10(-7) M)-precontracted mouse aorta, whereas no relaxation was observed in endothelium-denuded tissues. The A2BAR antagonist alloxazine (10(-5) M) shifted concentration-response curve for NECA (EC50 = 0.005 X 10(-5) M) to the right with an EC50 of 2.8 X 10(-5) M, demonstrating that this relaxation is partially dependent on functional endothelium mediated predominantly via A2BAR in this tissue. This conclusion was further supported by the following findings: 1) in the endothelium-intact mouse aorta, the EC50 values for NECA and adenosine were found to be 0.05 and 1.99 x 10(-4) M, respectively; however, in denuded endothelium, these values were 0.098 and 3.55 x 10(-4) M, respectively; 2) NECA-induced relaxation was significantly blocked by N-G-nitro-L-arginine methyl ester (L-NAME; 10(-4) M) in endothelium-intact tissues, which was reversed by pretreatment with L-arginine (10(-4) M), whereas no significant inhibition was found in endothelium-denuded tissues; 3) total nitrites and nitrates (NOx) in intact endothelium with L-NAME (10(-4) M) alone and in combination with L-arginine were 59% (P < 0.05) and 96%, respectively, in comparison with control (PE + NECA); and 4) endothelial nitric oxide synthase gene expression was found to be 67% (P < 0.05) less in endothelium-denuded as opposed to endothelium-intact mouse aorta. Thus these data demonstrate that adenosine-mediated vasorelaxation is partially dependent on A2BAR in mouse aorta.
引用
收藏
页码:H719 / H725
页数:7
相关论文
共 49 条
[1]
ADENOSINE RECEPTOR-MEDIATED RELAXATION OF PORCINE CORONARY-ARTERY IN PRESENCE AND ABSENCE OF ENDOTHELIUM [J].
ABEBE, W ;
MAKUJINA, SR ;
MUSTAFA, SJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (05) :H2018-H2025
[2]
ROLE OF NITRIC-OXIDE IN ADENOSINE RECEPTOR-MEDIATED RELAXATION OF PORCINE CORONARY-ARTERY [J].
ABEBE, W ;
HUSSAIN, T ;
OLANREWAJU, H ;
MUSTAFA, SJ .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 269 (05) :H1672-H1678
[3]
Adenosine receptor-mediated relaxation of rabbit airway smooth muscle: a role for nitric oxide [J].
Ali, S ;
Metzger, WJ ;
Olanrewaju, HA ;
Mustafa, SJ .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1997, 273 (03) :L581-L587
[4]
BRACKETT LE, 1994, BIOCHEM PHARMACOL, V47, P801
[5]
BRUNS RF, 1986, MOL PHARMACOL, V29, P331
[6]
Acetylcholine-induced relaxation in blood vessels from endothelial nitric oxide synthase knockout mice [J].
Chataigneau, T ;
Félétou, M ;
Huang, PL ;
Fishman, MC ;
Duhault, J ;
Vanhoutte, PM .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (01) :219-226
[7]
COLLIS MG, 1993, TRENDS PHARMACOL SCI, V14, P360
[8]
Role of endothelium in adenosine receptor-mediated vasorelaxation in hypertensive rats [J].
Fahim, M ;
Hussain, T ;
Mustafa, SJ .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 (05) :325-334
[9]
Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase [J].
Faraci, FM ;
Sigmund, CD ;
Shesely, EG ;
Maeda, N ;
Heistad, DD .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1998, 274 (02) :H564-H570
[10]
Feoktistov I, 1997, PHARMACOL REV, V49, P381